Voyager Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Voyager Therapeutics is a clinical-stage gene therapy company developing treatments for severe neurological diseases. The company focuses on leveraging advanced adeno-associated virus (AAV) capsids and payloads to deliver transformative therapies for conditions including Parkinson disease, Alzheimer disease, and other central nervous system disorders.